Prostate Cancer - Results from #20840

Prophylactic sildenafil citrate for improvement of erectile function in men treated by radiotherapy for prostate cancer - Abstract April 7, 2014

Use and outcomes of extended antibiotic prophylaxis in urologic cancer surgery - Abstract April 7, 2014

Evaluating the use of prostate-specific antigen as an instrument for early detection of prostate cancer beyond urologists: Results of a representative cross-sectional questionnaire study of general practitioners and internal specialists - Abstract April 7, 2014

The likelihood of death from prostate cancer in men with favorable or unfavorable intermediate-risk disease - Abstract April 7, 2014

Quantitative evaluation of bone metastases from prostate cancer with simultaneous [18F] choline PET/MRI: Combined SUV and ADC analysis - Abstract April 7, 2014

The impact of prostate volume, number of biopsy cores and American Urological Association symptom score on the sensitivity of cancer detection using the Prostate Cancer Prevention Trial risk calculator - Abstract April 7, 2014

Allogeneic versus autologous blood transfusion and survival after radical prostatectomy - Abstract April 7, 2014

Effects of surgeon variability on oncologic and functional outcomes in a population-based setting - Abstract April 7, 2014

Comparative effectiveness of robot-assisted versus open radical prostatectomy cancer control - Abstract April 7, 2014

Degarelix versus goserelin plus bicalutamide therapy for lower urinary tract symptom relief, prostate volume reduction and quality of life improvement in men with prostate cancer: A systematic review and meta-analysis - Abstract April 7, 2014

Evaluation of the prostate imaging reporting and data system for the detection of prostate cancer by the results of targeted biopsy of the prostate - Abstract April 4, 2014

11C-Choline PET/CT as a guide to radiation treatment planning of lymph-node relapses in prostate cancer patients - Abstract April 4, 2014

Mechanism of action and clinical activity of tasquinimod in castrate-resistant prostate cancer - Abstract April 4, 2014

Metastatic mucinous adenocarcinoma of the prostate with PSA value of 8.6 ng/mL at 5-year-followup after prostatectomy, radiotherapy, and androgen deprivation - Abstract April 4, 2014

Effect on therapeutic ratio of planning a boosted radiotherapy dose to the dominant intraprostatic tumour lesion within the prostate based on multifunctional MR parameters - Abstract April 4, 2014

Use of articulated registration for response assessment of individual metastatic bone lesions - Abstract April 4, 2014

Carboplatin plus irinotecan induced partial response in a patient with small cell carcinoma of the prostate; A case report - Abstract April 4, 2014

Caring for Alaska Native prostate cancer survivors in primary care: A survey of Alaska Tribal Health System providers - Abstract April 4, 2014

Radical prostatectomy or watchful waiting in early prostate cancer - Abstract April 4, 2014

Supporting prostate cancer focal therapy: A multidisciplinary International Consensus of Experts ("ICE") - Abstract April 4, 2014

Page 1043 of 1436